Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILON HEALTH, INC.

(AGL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

agilon health : Announces Pricing of Secondary Offering

09/09/2021 | 07:31pm EDT

agilon health, inc. (NYSE: AGL), the company transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients, announced the pricing of its previously announced underwritten public offering of 17,000,000 shares of its common stock by certain selling stockholders at a public offering price of $30.00 per share. Certain of these selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 2,550,000 shares of agilon health’s common stock. agilon health will not receive any proceeds from the secondary offering. The offering is expected to close on September 14, 2021, subject to customary closing conditions.

J.P. Morgan, Goldman Sachs & Co. LLC, and BofA Securities are acting as lead book-running managers for the proposed offering. Deutsche Bank Securities, Wells Fargo Securities, Wolfe | Nomura Strategic Alliance, William Blair, and Truist Securities are acting as additional book-running managers.

A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission on September 9, 2021. The offering is being made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204, or by email at prospectus-eq_fi@jpmchase.com; or Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing prospectus-ny@ny.email.gs.com; or BofA Securities, Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, or by email at dg.prospectus_requests@bofa.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

“Wolfe | Nomura Strategic Alliance” is the marketing name used by Wolfe Research Securities and Nomura Securities International, Inc. in connection with certain equity capital markets activities conducted jointly by the firms. For these activities, Nomura serves as the underwriter, placement agent, or initial purchaser (as applicable) and Wolfe Research Securities provides sales support services, investor education, and/or independent equity research services.

About agilon health

agilon health is transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients. Through our partnerships and our platform, agilon is leading the nation in creating the system we need – one built on the value of care, not the volume of fees. We honor the independence of local physicians and serve as their partners so they can be the doctors they trained to be. agilon provides the capital, data, payor relationships, executive experience and contract support that allow physician groups to take on the risk of total care for their most vulnerable patients. The result: healthier communities, and doctors who can devote the right amount of time with the patients who need it most. With rapidly growing appeal, agilon is scaled to grow and is here to help our nation’s best independent physician groups have a sustained, thriving future. Together, we are reinventing primary care.

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed secondary offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of agilon health, including those set forth in the Risk Factors section of agilon health’s most recent Quarterly Report on Form 10-Q and in the registration statement for this offering and the preliminary prospectus included therein, as filed with the Securities and Exchange Commission. Copies are available on the SEC’s website at www.sec.gov. agilon health undertakes no obligation to update these statements for revisions or changes after the date of this press release, except as required by law.


© Business Wire 2021
All news about AGILON HEALTH, INC.
10/20AGILON HEALTH : Jefferies Starts agilon health at Buy with $35 Price Target
MT
10/12AGILON HEALTH : Sets Date to Report Third Quarter 2021 Financial Results
BU
10/12Certain Stock Options of agilon health, inc. are subject to a Lock-Up Agreement Ending ..
CI
10/12Certain Common Stock of agilon health, inc. are subject to a Lock-Up Agreement Ending o..
CI
10/11THE BENEFITS OF VALUE-BASED CARE FOR : A Primary Care Physician Shares How She Serves Her ..
PU
10/07AGILON HEALTH : Names Chief People Officer
MT
10/07AGILON HEALTH : Names Mat Varghese as New Chief People Officer
BU
10/07Agilon health, inc. Appoints Mat Vargehese as New Chief People Officer, Effective Octob..
CI
10/07AGILON HEALTH : Zanesville Physician Recognized for Excellence in Senior Patient Care Hono..
PR
10/03AGILON HEALTH : Doctors Nationwide Recognized for Excellence in Senior Patient Care
PU
More news
Analyst Recommendations on AGILON HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 1 870 M - -
Net income 2021 -397 M - -
Net cash 2021 1 079 M - -
P/E ratio 2021 -23,6x
Yield 2021 -
Capitalization 9 268 M 9 268 M -
EV / Sales 2021 4,38x
EV / Sales 2022 3,15x
Nbr of Employees 550
Free-Float 98,5%
Chart AGILON HEALTH, INC.
Duration : Period :
agilon health, inc. Technical Analysis Chart | AGL | US00857U1079 | MarketScreener
Technical analysis trends AGILON HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 23,71 $
Average target price 39,89 $
Spread / Average Target 68,2%
EPS Revisions
Managers and Directors
Steven J. Sell President, Chief Executive Officer & Director
Timothy S. Bensley Chief Financial Officer
Ronald A. Williams Chairman
Benjamin Kornitzer Chief Medical & Quality Officer
Girish Venkatachaliah Chief Technology Officer
Sector and Competitors